General Info

InSite Vision Inc. is an ophthalmic products company that focuses on ocular infection, glaucoma, and retinal disease. The company specializes in three platform technologies: topical drug delivery, genomics and retinal drug delivery. InSite Vision has a portfolio of diagnostic and therapeutic products in early and late-stage development. The company s main product is AzaSite, which targets infection of the eye and contains azithromycin, a broad-spectrum antibiotic. InSite Vision launched AzaSite in the United States in 2006 while expanding this technology platform to include additional indications and product options for the global market. The company also produces DuraSite, the company s patented drug-delivery vehicle, which offers the benefit of a low-dosing regimen. InSite Vision Inc. maintains its headquarters in Alameda, Calif.